Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    " August 27, 2008":" September 26, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" August 27, 2008":" September 26, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed An Affect Management Intervention for Juvenile Offenders
Condition: HIV Infections
Interventions: Behavioral: Affect Management;   Behavioral: General Health Promotion
2 Completed Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients
Condition: HIV Infections
Interventions: Drug: Kaletra + Isentress;   Drug: Atripla
3 Completed IMARA, Adapting SiHLE for Detained African American Adolescent Females
Condition: HIV Infections
Intervention: Behavioral: IMARA HIV Prevention Intervention
4 Completed
Has Results
Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women
Condition: HIV Infections
Intervention: Drug: Raltegravir
5 Terminated Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy
Condition: HIV Infections
Intervention: Drug: Angiotensin 1-7
6 Completed Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia
Condition: HIV Infections
Intervention: Drug: Routine three-drug antiretroviral prophylaxis
7 Completed Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients
Condition: HIV Infections
Intervention: Drug: lopinavir/ritonavir and raltegravir
8 Completed Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine
Condition: HIV Infections
Intervention: Biological: Tat protein
9 Completed Effect of an Online Video-Based Intervention to Increase HIV Testing in Men Who Have Sex With Men in Peru
Condition: HIV Infections
Interventions: Device: HIV-testing motivational videos;   Device: Standard public health text
10 Completed
Has Results
BRAVO: Background Regimen of Raltegravir on Virologic Outcome
Condition: HIV Infections
Intervention: Drug: raltegravir
11 Completed
Has Results
Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
Condition: HIV Infections
Interventions: Drug: ATV/r;   Drug: DRV/r
12 Completed
Has Results
Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir and truvada;   Drug: Atazanavir, Norvir and Truvada
13 Unknown  Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism
Condition: HIV Infections
Interventions: Drug: Tenofovir + emtricitabine + efavirenz;   Drug: Tenofovir + emtricitabine + lopinavir/ritonavir
14 Unknown  Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment
Condition: HIV Infections
Intervention: Drug: Raltegravir and Atazanavir
15 Completed Assessment of Cytokine Values in Serum and by RT-PCR in HIV-1 Individuals With and Without HAART
Condition: HIV Infections
Intervention:
16 Completed Community-based Evaluation of a Pilot PMTCT Project in Kafue District
Conditions: Death;   HIV Infection
Intervention: Other: Community-based Survey
17 Completed Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China
Conditions: Opiate Dependence;   HIV Infections
Interventions: Behavioral: Behavioral Drug and HIV Risk Reduction Counseling (BDRC);   Behavioral: Drug counseling
18 Terminated
Has Results
A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071)
Condition: HIV
Interventions: Drug: Comparator: Raltegravir 400 mg b.i.d.;   Drug: Experimental: Raltegravir 800 mg q.d.;   Drug: TRUVADA™
19 Completed Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1265744 10 mg oral solution;   Drug: GSK1265744 5 mg tablet
20 Terminated A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects
Conditions: HIV;   Tuberculosis
Interventions: Drug: lopinavir/ritonavir;   Drug: rifabutin

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.